🏢
🏢 Company
Neurocrine Biosciences
American biopharmaceutical company
📊 Rating
1 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Pharmaceutical Acquisition (1)
- Rare Diseases (1)
🏷️ Keywords
Neurocrine Biosciences (1) · Soleno Therapeutics (1) · acquisition (1) · rare diseases (1) · Prader-Willi syndrome (1) · biotech (1) · pharmaceuticals (1) · merger (1)
📖 Key Information
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024.
📰 Related News (1)
-
🇺🇸 Neurocrine to buy Soleno Therapeutics for $2.9 billion
Neurocrine has offered $53 per Soleno share held, which represents a premium of about 34% to the stock's last close....